How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2026 · third_quarter · Q3
Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2026 · second_quarter · Q2
Source: Senate LDA
Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2026 · first_quarter · Q1
Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2025 · fourth_quarter · Q4
Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2025 · third_quarter · Q3
Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2025 · second_quarter · Q2
Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2025 · first_quarter · Q1
Federal marijuana reform, primarily descheduling legislation, such as the MORE Act and CAOA, as well as narrower related legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · fourth_quarter · 4A
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · third_quarter · 3A
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · second_quarter · 2A
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · first_quarter · 1A
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · fourth_quarter · Q4
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · third_quarter · Q3
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · second_quarter · Q2
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2024 · first_quarter · Q1
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2023 · fourth_quarter · 4A
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2023 · third_quarter · 3A
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2023 · fourth_quarter · Q4
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2023 · third_quarter · Q3
Federal marijuana reform, primarily descheduling legislation (such as the MORE Act and CAOA), as well as narrower related bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via ENACT CONSULTING, LLC
2023 · third_quarter · RR
Marijuana policy reform, including improving and seeking passage of proposals to remove marijuana from the CSA, as well as narrower marijuana-focused legislation, and marijuana-related provisions in appropriations bills.